Max Servin-Rojas

Médico mexicano/morelense 🇲🇽 | General Surgery Resident U of U | Former Research Fellow Mass Genera | Amateur cook and barista | views are my own

[Max Servin-Rojas @servinrojasmd]

Representing @UofUSurgery at the Central Surgical Association Annual Meeting.

[Max Servin-Rojas @servinrojasmd]

@AmairanAlicia @motazqadan Felicidades Alicia!

[Max Servin-Rojas @servinrojasmd]

@EduardoNute A mi me gusta el Hamilton Murph. Se ve bastante bien tanto con extensible de piel como de acero.

[Sean Langenfeld @SeanLangenfeld]

"8.6 fold increase" was 0.3%-->2.6%.

"Higher operative recurrence" was 3.78% for robot vs 3.21% for lap.

This was Medicare-only so everyone above age 65, and much of the meaningful variables (pain, return to work, etc) were not measured.

This obviously doesn't control for so many things on the patient and surgeon end, so such modest differences don't seem meaningful to a non-hernia surgeon such as myself.

One thing to consider, as well, is robot acting as a bridge and allowing surgeons to tackle more difficult hernias MIS that they would have done open (and thus a higher recurrence would be expected, no?)

Also, table 1 shows modest-but-likely-statistically-significant differences between lap and robot patients in several important patient characteristics with robots having higher rates of diabetes, COPD, PVD, CKD, liver disease, etc.

If this study proves anything to you, it's likely confirmation bias.

[Max Servin-Rojas @servinrojasmd]

Morning homemade latte.

[Max Servin-Rojas @servinrojasmd]

@FlavioRochaMD @SyedAAhmad5 @HalletJulie @JadAbouKhalil @laleh_melstrom @ZhiVenFongMD https://t.co/7aaQdVY47i

https://t.co/1yzW3Lhn2S

[Max Servin-Rojas @servinrojasmd]

@FlavioRochaMD @SyedAAhmad5 @HalletJulie @JadAbouKhalil @laleh_melstrom @ZhiVenFongMD My thought is that it goes beyond that. Stage migration may be part of it, but there’s interesting data from colon cancer showing that patients with higher LNY also have a more robust immune responses. Makes me wonder if something similar happens in PDAC.

[Marco Ventin MD @MVentinMD]

Honored to present our @JAMASurgery research today at the #SSO2026! Grateful to all the mentors and the scientific committee for this podium. Great HPB debates! @UCIrvineSurgery

[Max Servin-Rojas @servinrojasmd]

@isa_ramul Es necesario hacer eso? 🥲

[Max Servin-Rojas @servinrojasmd]

@TomVargheseJr @eljefe_md @motazqadan @TCGamblin Thank you Dr Varghese!

[Max Servin-Rojas @servinrojasmd]

Honored to have our abstract accepted for an oral presentation at the 83rd annual CSA meeting.

Also, extra happy to share first authorship with my great friend @eljefe_md.

Thankful to my mentors Dr. Baker, @motazqadan, and @TCGamblin.

See you in Chicago!

[Max Servin-Rojas @servinrojasmd]

@Justice_69 @laloprado64 En México. En Estados Unidos es parte del entrenamiento del cirujano general (y es de gran utilidad).

[Zhi Ven Fong, MD MPH DrPH @ZhiVenFongMD]

Our @MayoCancerCare Enterprise paper is finally out!

1,446 pts w “upfront resectable” PDAC.

Any vein abutment portended ⬇️OS, but this diff was mitigated when NAT was used.

⬆️aggressive vein resections didn’t change OS.

Time to redefine resectability?

https://t.co/7ay9d910lH

[Max Servin-Rojas @servinrojasmd]

@jlberistain @CirujanoGZ Llevo tres años dejando cosas de valor en vestidores y oficinas compartidas y jamás se me ha perdido algo.

En México me robaban hasta mis pantalones blancos cuando era estudiante.

[Max Servin-Rojas @servinrojasmd]

@zerrweck Se ve sabroso. Nomás lo pediría sin palmito.

[Max Servin-Rojas @servinrojasmd]

@zerrweck Juicy

[Max Servin-Rojas @servinrojasmd]

@GabriellaRouge Bumetanida combinado con metolazona?!

[Max Servin-Rojas @servinrojasmd]

@CirujanoGZ La maniobra de Pringle también es útil.

[Max Servin-Rojas @servinrojasmd]

@CirujanoGZ No es buena idea. No quiero sonar pesimista, pero todos los cambios en los últimos años han sido malos. Desde el cambio del formato del examen (electrónico a escrito), sedes del examen, el incremento no planeado de plazas. En fin.